165 related articles for article (PubMed ID: 35717681)
41. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
42. Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Schöffski P; Wozniak A; Stacchiotti S; Rutkowski P; Blay JY; Lindner LH; Strauss SJ; Anthoney A; Duffaud F; Richter S; Grünwald V; Leahy MG; Reichardt P; Sufliarsky J; van der Graaf WT; Sciot R; Debiec-Rychter M; van Cann T; Marréaud S; Lia M; Raveloarivahy T; Collette L; Bauer S
Ann Oncol; 2017 Dec; 28(12):3000-3008. PubMed ID: 28950372
[TBL] [Abstract][Full Text] [Related]
43. Biology and management of clear cell sarcoma: state of the art and future perspectives.
Cornillie J; van Cann T; Wozniak A; Hompes D; Schöffski P
Expert Rev Anticancer Ther; 2016 Aug; 16(8):839-45. PubMed ID: 27253849
[TBL] [Abstract][Full Text] [Related]
44. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.
Hantschke M; Mentzel T; Rütten A; Palmedo G; Calonje E; Lazar AJ; Kutzner H
Am J Surg Pathol; 2010 Feb; 34(2):216-22. PubMed ID: 20087159
[TBL] [Abstract][Full Text] [Related]
46. EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.
Möller E; Praz V; Rajendran S; Dong R; Cauderay A; Xing YH; Lee L; Fusco C; Broye LC; Cironi L; Iyer S; Rengarajan S; Awad ME; Naigles B; Letovanec I; Ormas N; Finzi G; La Rosa S; Sessa F; Chebib I; Petur Nielsen G; Digklia A; Spentzos D; Cote GM; Choy E; Aryee M; Stamenkovic I; Boulay G; Rivera MN; Riggi N
Nat Commun; 2022 Apr; 13(1):2267. PubMed ID: 35477713
[TBL] [Abstract][Full Text] [Related]
47. Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman.
Asif S; Hurley BJ; Haroon S; Lele S; Sharma B
Oncology (Williston Park); 2023 Oct; 37(10):412-416. PubMed ID: 37877807
[TBL] [Abstract][Full Text] [Related]
48. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients.
Kawai A; Hosono A; Nakayama R; Matsumine A; Matsumoto S; Ueda T; Tsuchiya H; Beppu Y; Morioka H; Yabe H;
Cancer; 2007 Jan; 109(1):109-16. PubMed ID: 17133413
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
[TBL] [Abstract][Full Text] [Related]
50. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
51. The real-world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post-ALTER0203 trial era.
Zhang RS; Liu J; Deng YT; Wu X; Jiang Y
Cancer Med; 2022 Jun; 11(11):2271-2283. PubMed ID: 35191609
[TBL] [Abstract][Full Text] [Related]
52. Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread--results of a large prospective trial.
Andreou D; Boldt H; Werner M; Hamann C; Pink D; Tunn PU
Ann Oncol; 2013 May; 24(5):1400-5. PubMed ID: 23372051
[TBL] [Abstract][Full Text] [Related]
53. Clear cell sarcoma: state-of-the art and perspectives.
Wetterwald L; Riggi N; Kyriazoglou A; Dei Tos G; Dei Tos A; Digklia A
Expert Rev Anticancer Ther; 2023 Mar; 23(3):235-242. PubMed ID: 36811446
[TBL] [Abstract][Full Text] [Related]
54. Anlotinib treatment in elderly patients with unresectable or metastatic soft tissue sarcoma: a retrospective study.
Zhang XY; Liu J; Deng YT; Jiang Y
Anticancer Drugs; 2022 Jan; 33(1):e519-e524. PubMed ID: 34282747
[TBL] [Abstract][Full Text] [Related]
55. Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.
Jagodzińska-Mucha P; Świtaj T; Kozak K; Koseła-Paterczyk H; Klimczak A; Ługowska I; Rogala P; Wągrodzki M; Falkowski S; Rutkowski P
Tumori; 2017 May; 103(3):231-235. PubMed ID: 28291905
[TBL] [Abstract][Full Text] [Related]
56. First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial.
Chawla SP; Papai Z; Mukhametshina G; Sankhala K; Vasylyev L; Fedenko A; Khamly K; Ganjoo K; Nagarkar R; Wieland S; Levitt DJ
JAMA Oncol; 2015 Dec; 1(9):1272-80. PubMed ID: 26378637
[TBL] [Abstract][Full Text] [Related]
57. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
58. A rare case of primary dermal clear cell sarcoma with focal epidermotropism: An entity difficult to distinguish from melanoma.
Nawrocki S; Fitzhugh VA; Groisberg R; Aviv HA; Maghari A
J Cutan Pathol; 2020 Jul; 47(7):621-624. PubMed ID: 32012324
[TBL] [Abstract][Full Text] [Related]
59. Clear cell sarcoma of soft tissues in children and young adults: the St. Jude Children's Research Hospital experience.
Parasuraman S; Rao BN; Bodner S; Cain A; Pratt CB; Merchant TE; Pappo AS
Pediatr Hematol Oncol; 1999; 16(6):539-44. PubMed ID: 10599094
[TBL] [Abstract][Full Text] [Related]
60. Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).
Schmitt T; Mayer-Steinacker R; Mayer F; Grünwald V; Schütte J; Hartmann JT; Kasper B; Hüsing J; Hajda J; Ottawa G; Mechtersheimer G; Mikus G; Burhenne J; Lehmann L; Heilig CE; Ho AD; Egerer G
Eur J Cancer; 2016 Sep; 64():74-82. PubMed ID: 27367154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
